LH
Income statement / Annual
Last year (2024), Laboratory Corporation of America Holdings's total revenue was $13.01 B,
an increase of 6.97% from the previous year.
In 2024, Laboratory Corporation of America Holdings's net income was $746.00 M.
See Laboratory Corporation of America Holdings,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$13.01 B |
$12.16 B |
$14.88 B |
$16.12 B |
$13.98 B |
$11.55 B |
$11.33 B |
$10.44 B |
$9.64 B |
$8.68 B |
| Cost of Revenue |
$9.51 B
|
$8.80 B
|
$10.49 B
|
$10.50 B
|
$9.03 B
|
$8.30 B
|
$8.16 B
|
$6.98 B
|
$6.46 B
|
$5.78 B
|
| Gross Profit |
$3.50 B
|
$3.36 B
|
$4.39 B
|
$5.62 B
|
$4.95 B
|
$3.25 B
|
$3.18 B
|
$3.46 B
|
$3.18 B
|
$2.90 B
|
| Gross Profit Ratio |
0.27
|
0.28
|
0.29
|
0.35
|
0.35
|
0.28
|
0.28
|
0.33
|
0.33
|
0.33
|
| Research and Development Expenses |
$0.00
|
$2.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$2.23 B
|
$2.02 B
|
$2.00 B
|
$1.95 B
|
$1.73 B
|
$1.62 B
|
$1.57 B
|
$1.81 B
|
$1.63 B
|
$1.62 B
|
| Other Expenses |
$166.30 M
|
$615.90 M
|
$259.30 M
|
$369.60 M
|
$275.40 M
|
$243.20 M
|
$167.70 M
|
-$7.60 M
|
$2.60 M
|
-$7.80 M
|
| Operating Expenses |
$2.40 B
|
$2.64 B
|
$2.26 B
|
$2.32 B
|
$2.00 B
|
$1.87 B
|
$1.80 B
|
$2.03 B
|
$1.81 B
|
$1.79 B
|
| Cost And Expenses |
$11.90 B
|
$11.44 B
|
$12.75 B
|
$12.82 B
|
$11.03 B
|
$10.17 B
|
$9.96 B
|
$9.01 B
|
$8.27 B
|
$7.56 B
|
| Interest Income |
$0.00
|
$0.00
|
$8.90 M
|
$10.20 M
|
$10.30 M
|
$8.80 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$208.30 M
|
$199.60 M
|
$180.30 M
|
$212.10 M
|
$207.40 M
|
$240.70 M
|
$244.20 M
|
$235.10 M
|
$219.10 M
|
$274.90 M
|
| Depreciation & Amortization |
$643.50 M
|
$577.30 M
|
$537.20 M
|
$940.00 M
|
$825.00 M
|
$771.30 M
|
$552.10 M
|
$533.20 M
|
$490.60 M
|
$457.80 M
|
| EBITDA |
$1.78 B |
$1.35 B |
$1.95 B |
$4.28 B |
$3.25 B |
$2.12 B |
$2.06 B |
$1.85 B |
$1.81 B |
$1.58 B |
| EBITDA Ratio |
0.14
|
0.11
|
0.18
|
0.26
|
0.25
|
0.17
|
0.19
|
0.19
|
0.2
|
0.18
|
| Operating Income Ratio |
0.09
|
0.06
|
0.12
|
0.2
|
0.17
|
0.12
|
0.12
|
0.13
|
0.14
|
0.12
|
| Total Other Income/Expenses Net |
-$146.30 M
|
-$156.70 M
|
-$199.10 M
|
-$132.90 M
|
-$226.30 M
|
-$225.30 M
|
-$57.40 M
|
-$227.70 M
|
-$206.90 M
|
-$270.80 M
|
| Income Before Tax |
$959.50 M
|
$568.90 M
|
$1.58 B
|
$3.13 B
|
$2.22 B
|
$1.10 B
|
$1.27 B
|
$1.13 B
|
$1.11 B
|
$732.10 M
|
| Income Before Tax Ratio |
0.07
|
0.05
|
0.11
|
0.19
|
0.16
|
0.1
|
0.11
|
0.11
|
0.11
|
0.08
|
| Income Tax Expense |
$212.40 M
|
$188.50 M
|
$302.00 M
|
$747.10 M
|
$662.10 M
|
$280.00 M
|
$384.40 M
|
-$139.10 M
|
$372.30 M
|
$294.10 M
|
| Net Income |
$746.00 M
|
$418.00 M
|
$1.28 B
|
$2.38 B
|
$1.56 B
|
$823.80 M
|
$883.70 M
|
$1.27 B
|
$732.10 M
|
$436.90 M
|
| Net Income Ratio |
0.06
|
0.03
|
0.09
|
0.15
|
0.11
|
0.07
|
0.08
|
0.12
|
0.08
|
0.05
|
| EPS |
8.92 |
4.8 |
14.04 |
24.58 |
15.99 |
8.41 |
8.71 |
12.39 |
7.14 |
4.42 |
| EPS Diluted |
8.86 |
4.77 |
13.96 |
24.38 |
15.88 |
8.36 |
8.61 |
12.21 |
7.02 |
4.34 |
| Weighted Average Shares Out |
$83.60 M
|
$87.10 M
|
$91.10 M
|
$96.70 M
|
$97.30 M
|
$97.90 M
|
$101.40 M
|
$102.40 M
|
$102.50 M
|
$98.80 M
|
| Weighted Average Shares Out Diluted |
$84.20 M
|
$87.60 M
|
$91.60 M
|
$97.50 M
|
$98.00 M
|
$98.60 M
|
$102.60 M
|
$103.90 M
|
$104.30 M
|
$100.60 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
